Cargando…
Is raloxifene associated with lower risk of mortality in postmenopausal women with vertebral fractures after vertebroplasty?: a hospital-based analysis
BACKGROUND: Osteoporotic fractures are associated with mortality in postmenopausal woman. Whether raloxifen treatment after vertebroplasty can reduce mortality is unclear in this group. To compare the effect of raloxifene and no osteoporosis treatment on the risk of mortality after vertebroplasty, w...
Autores principales: | Su, Fu-Mei, Chen, Ying-Chou, Cheng, Tien-Tsai, Lin, Wei-Che, Lui, Chun-Chung |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4545327/ https://www.ncbi.nlm.nih.gov/pubmed/26286481 http://dx.doi.org/10.1186/s12891-015-0670-7 |
Ejemplares similares
-
Risk factors of adjacent vertebral collapse after percutaneous vertebroplasty for osteoporotic vertebral fracture in postmenopausal women
por: Takahara, Kenji, et al.
Publicado: (2016) -
Pharmacogenomics Study for Raloxifene in Postmenopausal Female with Osteoporosis
por: Lu, Hsing-Fang, et al.
Publicado: (2020) -
Vertebroplasty for osteoporotic vertebral fracture
por: Roux, Christian, et al.
Publicado: (2021) -
Vertebroplasty in osteoporosis-related vertebral fractures
por: Sadat-Ali, Mir
Publicado: (2008) -
Denosumab Is Superior to Raloxifene in Lowering Risks of Mortality and Ischemic Stroke in Osteoporotic Women
por: Liu, Ting-Chun, et al.
Publicado: (2023)